Placeholder Banner

Programming Updates to the 2012 BIO International Convention

March 8, 2012
With Convention less than four months away, things are quickly falling in to place with several programming updates to note!

A total of 115 breakout sessions have been confirmed and scheduled, including 18 international case studies.  Session organizers are currently finalizing speakers.  All session descriptions and confirmed speakers are available on myBIO.

Even after all of the session submissions work, we asked for more session ideas! We recently completed a call for “Late-Breaking” sessions in order to attract proposals with new information that was not yet known at the time of the original call for sessions in September of 2011.  A spot for one late-breaking session is reserved in eleven of the thirteen tracks.  Our tireless volunteer Program Committee will once again put their heads down and review the submissions along with our staff and selected sessions will be announced by the end of March.

New to the program this year, we will offer a professional development track during the Convention. One professional development breakout session will be offered each day during the Convention that will cover tips and tools on career advancement. Sessions in this track will provide attendees with ideas to foster collaborative innovation through professional development and educational efforts.

There will be a total of six Super Sessions on the 2012 program. Super Sessions are open to Full Convention Access, Convention Access and Education & Exhibition Access registrants.  Super Session sponsors include: Burrill & Company; Campbell Alliance; Ernst & Young; Eli Lilly and Company and MedImmune.

Beyond Borders: Ernst & Young’s Annual Biotechnology Industry Report

Sponsored by Ernst & Young

Tuesday, June 19, 10:00 a.m. – 11:30 a.m.

Moderators: Glen Giovannetti, Partner and Global Biotechnology Leader, Ernst & Young LLP and Gautam Jaggi, Senior Manager and Editor, Beyond Borders and Progressions, Ernst & Young LLP

Burrill State-of-the-Industry Report

Sponsored by Burrill & Company

Tuesday, June 19, 2:00 p.m. – 3:30 p.m.

Speaker: G. Steven Burrill, Chief Executive Officer, Burrill & Company

International Leaders Share Their Worldview: Scientific American’s Regional Bio-Innovation Scorecard

Tuesday, June 19, 3:45 p.m. – 5:15 p.m.

Moderator & Speaker: Fareed Zakaria, CNN host, Editor-at-Large of TIME Magazine, Washington Post columnist and New York Times bestselling author

* This Super Sessions is open to Full Convention Access, Convention Access, Education & Exhibition Access, and Exhibit Booth Personal registrants.

After the Honeymoon – Integrating the R&D Growth Engine

Sponsored by Campbell Alliance

Wednesday, June 20, 10:00 a.m. – 11:30 a.m.

Moderated by Ben Bonifant, Practice Area Leader, Campbell Alliance and David Thomas, Director, Industry Research & Analysis, Biotechnology Industry Organization

Speaker:  Peter Greenleaf, President, MedImmune

Pre-Competitive Collaboration: Innovation of the Future?

Sponsored by Eli Lilly and Company

Wednesday, June 20, 2:00 p.m. – 3:30 p.m.

Speaker: Jan M. Lundberg, PhD, Executive Vice President, Science & Technology and President, Lilly Research Laboratories, Eli Lilly and Company

PDUFA V: Impact on Innovation, Patients, and Modern Medicines

Sponsored by MedImmune

Wednesday, June 20, 3:45 p.m. – 5:15 p.m.

Speaker:  Peter Greenleaf, President, MedImmune

In addition to the Super Sessions, BIO will host various co-located events and special programs. Below are highlights of these programs:

Translational Research Forum - From Bench to Bedside in a Bioeconomy: University Models that Catalyze Economic Growth and Patient Access

Sponsored by Millennium: The Takeda Oncology Company

Monday, June 18, 1:30 p.m. – 5:30 p.m.

Dr. Robert A. Brown, President, Boston University, will discuss the role of universities in translational medicine during the keynote at this year’s Translational Research Forum.

Leadership Summit: Harvesting the Commercial Potential of Emerging Agricultural and Industrial Biotechnologies

Sponsored by Bayer CropScience

Monday, June 18, 1:00 p.m. – 4:30 p.m.

The Summit will examine the needs, risks, and strategies for financing development and commercialization of innovative agricultural and industrial biotechnology products, and discuss the role various institutions play in supporting technologies that lead to opportunities for investment and drive innovation in the marketplace.

Rare Diseases Forum:  Emerging Strategies, Challenges, and Partnerships

Sponsored by Genzyme, a Sanofi Company & Millennium: The Takeda Oncology Company

Tuesday, June 19, 8:00 a.m. – 5:00 p.m. & Wednesday, June 20, 8:30 a.m. – 3:30 p.m.

With input from the National Organization for Rare Disorders (NORD) and Centric Health Resources, the Forum will provide attendees a unique perspective on the orphan drug marketplace, regulatory considerations and much more.

8th Annual Biotechnology Entrepreneurship Boot Camp

Sponsored by Pepper Hamilton LLP

Sunday, June 17, 8:00 a.m. – 7:30 p.m. & Monday, June 18, 8:15 a.m. – 6:45 p.m.

Biotechnology Entrepreneurship Boot Camp is an intensive, two-day program that walks attendees through the necessary steps and provides training for the skills needed to transform technology and invention into a viable company. Visit for more information on this unique program.

Product Delivery Workshop: Navigating the Patch to Commercialization

Monday, June 18, 8:30 a.m. – 5:00 p.m. & Tuesday, June 19, 8:30 p.m. – 5:00 p.m.

The Workshop will provide guidance on how to navigate aggressive competition, regulatory pressures and a thin budget to get a product to market. Attendees will outline and evaluate best practices in commercialization, then practice the concepts during a competitive team simulation. Visit for more information and to register today.

To view the complete educational line-up at the 2012 BIO International Convention visit myBIO.